| Literature DB >> 28417910 |
Lu Qin1,2, Qi-Rong Wang3,4, Zi-Long Fang5, Ting Wang6,7, Ai-Qi Yu8,9, Yu-Jie Zhou10,11, Yi Zheng12,13, Mu-Qing Yi14.
Abstract
Purpose: To examine the effects of commercially available sports beverages with various components on substrate metabolism and subsequent performance.Entities:
Keywords: cycling; drinks; metabolism; non-fasted state; time to exhaustion; two session training
Mesh:
Substances:
Year: 2017 PMID: 28417910 PMCID: PMC5409716 DOI: 10.3390/nu9040377
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Ingredients of prescribed sports beverages. CHO: carbohydrate; PRO: protein.
| Ingredients information | L-CHO | H-CHO | CHO + PRO |
|---|---|---|---|
| Energy density (kJ/100 g) | 1500 | 1550 | 1581 |
| CHO (g/100 g) | 90 | 92 | 70.3 |
| FAT (g/100 g) | <0.5 | <0.5 | <0.5 |
| PRO (g/100 g) | 0 | 0 | 27 |
| CHO molecular weight (g/mol) | <1500 | 500,000~750,000 | 337.8 |
Figure 1Blood glucose (BG) change after ingestion of different solutions. a: vs. Glucose, p < 0.05; aa: vs. Glucose, p < 0.01; b: vs. L-CHO, p < 0.05; bb: vs. L-CHO, p < 0.01; c: vs. H-CHO, p < 0.05. CHO: carbohydrate; H-CHO high molecular weight CHO; L-CHO low molecular weight CHO; PRO: protein.
Incremental area under the curve (IAUC) and glycemic index (GI) of prescribed sports beverage.
| Type of Solutions | IAUC | GI |
|---|---|---|
| Glucose | 143.16 ± 13.23 | 100 |
| L-CHO | 178.97 ± 36.94 | 117.70 ± 14.25 |
| H-CHO | 149.50 ± 19.20 | 105.50 ± 12.82 |
| CHO + PRO | 94.74 ± 10.30 | 67.23 ± 5.88 |
Composition of macronutrients in standardized meals.
| Standardized Meals | Characteristics of Macronutrients | CHO | PRO | FAT |
|---|---|---|---|---|
| Breakfast | Content (g) | 77.4 | 23.0 | 8.3 |
| Energy (%) | 55.65 | 16.52 | 27.83 | |
| Total energy (kcal) | 556.5 | |||
| Lunch | Content (g) | 95.1 | 38.2 | 35.8 |
| Energy (%) | 44.33 | 17.90 | 37.77 | |
| Total energy (kcal) | 852.3 |
Figure 2Changes of blood glucose (BG), lactate (LA) and free fatty acid (FFA) during the first exercise session (#: vs. 0 min, p < 0.05; *: vs. placebo (PLA), p < 0.05).
Blood hormonal change during exercise following treatments.
| Blood Hormonal Measurements | 0 min | 30 min | 60 min |
|---|---|---|---|
| L-CHO | 224.13 ± 30.84 | 67.10 ± 27.31 # | 104.36 ± 22.49 *,# |
| H-CHO | 245.45 ± 43.15 | 81.97 ± 11.91 # | 83.26 ± 13.15 *,# |
| CHO + PRO | 169.86 ± 31.56 | 103.64 ± 21.47 | 107.09 ± 21.46 * |
| PLA | 188.74 ± 31.78 | 61.27 ± 11.22 # | 27.38 ± 3.50 # |
| L-CHO | 41.85 ± 12.66 | 51.00 ± 9.45 | 56.97 ± 8.43 |
| H-CHO | 54.91 ± 8.50 | 47.30 ± 13.87 | 51.58 ± 13.08 |
| CHO + PRO | 33.16 ± 9.29 | 52.60 ± 15.70 | 62.72 ± 22.11 |
| PLA | 53.24 ± 10.56 | 67.40 ± 12.31 | 74.89 ± 11.13 |
| L-CHO | 15.36 ± 1.60 | 17.32 ± 3.31 | 16.09 ± 1.27 |
| H-CHO | 14.68 ± 1.90 | 15.79 ± 1.74 | 14.63 ± 1.09 |
| CHO + PRO | 20.99 ± 7.79 | 15.03 ± 1.09 | 16.07 ± 1.47 |
| PLA | 13.59 ± 1.16 | 13.70 ± 1.11 | 14.49 ± 1.27 |
#: vs. 0 min, p < 0.05; *: vs. PLA, p < 0.05.
Figure 3CHO oxidation rate in the first and second exercise sessions in study II (#: vs. 0 min in the same exercise bout, p < 0.05).
Figure 4FAT oxidation rate in the first and second exercise sessions in study II (#: vs. 0 min in the same exercise bout, p < 0.05; a: vs. 2nd exercise session in 60 min, p < 0.05).
Rating of perceived exertion following treatments.
| Treatments | Sample size ( | 0 min | 15 min | 30 min | 45 min | 60 min |
|---|---|---|---|---|---|---|
| 10 | 10 | 10 | 10 | 10 | ||
| L-CHO | 8.10 ± 0.52 | 12.80 ± 0.49 # | 14.80 ± 0.94 # | 16.40 ± 0.76 # | 17.30 ± 0.86 # | |
| H-CHO | 7.90 ± 0.48 | 12.60 ± 0.52 # | 14.00 ± 0.59 # | 14.20 ± 0.61 # | 13.90 ± 1.03 # | |
| CHO-PRO | 8.70 ± 0.66 | 12.50 ± 0.68 # | 14.20 ± 0.78 # | 15.30 ± 0.86 # | 15.70 ± 0.96 # | |
| PLA | 9.00 ± 0.59 | 12.60 ± 0.47 # | 13.80 ± 0.29 # | 15.00 ± 0.51 # | 15.20 ± 0.61 # | |
| L-CHO | 10 | 10 | 10 | 8 | 7 | |
| 8.78 ± 0.62 | 12.89 ± 0.75 # | 14.56 ± 0.91 # | 16.12 ± 0.79 # | 17.42 ± 0.97 # | ||
| H-CHO | 10 | 10 | 10 | 7 | 5 | |
| 8.56 ± 0.82 | 12.22 ± 0.55 # | 15.11 ± 0.48 # | 16.29 ± 0.94 # | 17.40 ± 1.29 # | ||
| CHO-PRO | 10 | 10 | 10 | 9 | 7 | |
| 8.90 ± 0.60 | 14.10 ± 0.48 # | 15.60 ± 0.73 # | 16.55 ± 0.73 # | 17.14 ± 0.83 # | ||
| PLA | 10 | 10 | 10 | 9 | 8 | |
| 9.00 ± 0.59 | 12.80 ± 0.61 # | 14.40 ± 0.65 #,* | 14.67 ± 0.73 # | 15.75 ± 0.76 # |
1st exercise = the first exercise session; 2nd exercise = the second exercise session; #: vs. 0 min, p < 0.05.; *: v.s. 15 min, p < 0.05.
Figure 5Time to exhaustion (TTE) following treatments.